" class="no-js "lang="en-US"> ScreenPoint Medical - Medtech Alert
Friday, September 12, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
ScreenPoint Medical | Pharmtech Focus

ScreenPoint Medical

About ScreenPoint Medical

ScreenPoint Medical

ScreenPoint is a leading company that develops and markets image analysis and machine learning applications and services to improve early detection of breast cancer. The company is a spin-off of the Radboud University in Nijmegen. Our product Transpara uses the latest developments in machine learning such as Deep Learning and is trained with very large well curated databases of screening mammograms. Research and development at ScreenPoint is aimed at improving performance to the level of expert radiologists and beyond.

Related Story

Artificial Intelligence

 A Study With Over 2

A Study With Over 2,000 Cancers Missed by Screening Shows That Transpara AI Can Effectively Help Detect Breast Cancer Earlier

February 15 2022

ScreenPoint Medical‘s Transpara AI decision support system can help radiologists to identify potential breast cancers […]

Fundraising

 ScreenPoint Raises $28M in Series C Funding Led by Global ScaleUp Investor Insight Partners | Pharmtech Focus

ScreenPoint Raises $28M in Series C Funding Led by Global ScaleUp Investor Insight Partners

July 28 2021

Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning […]